The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
The nutrient-sensitive kinase mammalian target of rapamycin (mTOR) and its downstream target S6 kinase (S6K) are involved in amino acid–induced insulin resistance. Whether the mTOR/S6K pathway directly modulates glucose metabolism in humans is unknown. We studied 11 healthy men (29 years old, BMI 23 kg/m2) twice in random order after oral administration of 6 mg rapamycin, a specific mTOR inhibitor, or placebo. An amino acid mixture was infused to activate mTOR, and somatostatin-insulin-glucose clamps created conditions of low peripheral hyperinsulinemia (∼100 pmol/l, 0–180 min) and prandial-like peripheral hyperinsulinemia (∼450 pmol/l, 180–360 min). Glucose turnover was assessed using d-[6,6-2H2]glucose infusion (n = 8). Skeletal muscle biopsies were performed at baseline and during prandial-like peripheral hyperinsulinemia (n = 3). At low peripheral hyperinsulinemia, whole-body glucose uptake was not affected by rapamycin. During prandial-like peripheral hyperinsulinemia, rapamycin increased glucose uptake compared with placebo by 17% (Rd|300–360 min, 75 ± 5 vs. 64 ± 5 μmol · kg−1 · min−1, P = 0.0008). Rapamycin affected endogenous glucose production neither at baseline nor during low or prandial-like peripheral hyperinsulinemia. Combined hyperaminoacidemia and prandial-like hyperinsulinemia increased S6K phosphorylation and inhibitory insulin receptor substrate-1 (IRS-1) phosphorylation at Ser312 and Ser636 in the placebo group. Rapamycin partially inhibited this increase in mTOR-mediated S6K phosphorylation and IRS-1 Ser312 and Ser636 phosphorylation. In conclusion, rapamycin stimulates insulin-mediated glucose uptake in man under conditions known to activate the mTOR/S6K pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [39]
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [39]
In the citing paper
“Inhibition of mTOR/p70 S6K with rapamycin restores insulin sensitivity caused by amino acids in human skeletal muscle [155,156].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In addition to polygenic predisposition, environmental factors including quality and quantity of food supply, dietary behavior, and physical activity are of major importance for the development of type 2 diabetes (4,5).”
BackgroundTOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677 · cited 3×
“Recent reports indicate that the activity of the mTOR pathway is increased in rodent models of obesity and that mice deficient in S6 kinase (S6K), a downstream effector of mTOR, are protected against diet-induced insulin resistance (20,21).”
BackgroundMethodMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Kahan, B. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02480-6 · Cited by 913
Research works printed but not linked: 1
- Krebs M, Roden M: Nutrient-induced insulin resistance in human skeletal muscle. Curr Med Chem 11:901-908, 2004 · DOI · Paper page
Cited by
Items 101–200 of 230
Agnoux, A. M., Antignac, J., Simard, G., Poupeau, G., Darmaun, D., Parnet, P., & Alexandre-Gouabau, M. C. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00015.2014 · Cited by 48
Parasite excretory‐secretory products and their effects on metabolic syndrome
Crowe, J., Lumb, F. E., Harnett, M. M., & Harnett, W. (2017) · Parasite Immunology · doi:10.1111/pim.12410 · Cited by 45
Current challenges in islet transplantation
Leitão, C. B., Cure, P., Tharavanij, T., Baidal, D. A., & Alejandro, R. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0057-3 · Cited by 48
Branched chain amino acids and metabolic regulation
Wang, C., & Guo, F. (2013) · Chinese Science Bulletin · doi:10.1007/s11434-013-5681-x · Cited by 47
The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials
Malley, C. O., & Pidgeon, G. P. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.11.003 · Cited by 49
Mammalian Target of Rapamycin and Diabetes: What Does the Current Evidence Tell Us?
Vodenik, B., Rovira, J., & Campistol, J. M. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.06.159 · Cited by 45
Koschei the immortal and anti-aging drugs
Blagosklonny, M. V. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.520 · Cited by 42
Copps, K. D., Hançer, N. J., Qiu, W., & White, M. F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714915 · Cited by 41
Liao, Q., Shi, D., Zheng, W., Xu, X., & Ying-hao, Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.024 · Cited by 46
mTOR function in skeletal muscle: a focal point for overnutrition and exercise
Rivas, D. A., Lessard, S. J., & Coffey, V. G. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-073 · Cited by 40
Metformin: An Inhibitor of mTORC1 Signaling
Melnik, B. C., & Schmitz, G. (2014) · Cited by 44
Dietary methionine restriction improves glucose metabolism in the skeletal muscle of obese mice
Luo, T., Yang, Y., Xu, Y., Gao, Q., Wu, G., Jiang, Y., Sun, J., Shi, Y., & Le, G. (2019) · Food & Function · doi:10.1039/c8fo02571a · Cited by 43
Kido, K., Sase, K., Yokokawa, T., & Fujita, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65397-z · Cited by 43
NOX4/H 2 O 2 /mTORC1 Pathway in Salt-Induced Hypertension and Kidney Injury
Kumar, V., Kurth, T. M., Zheleznova, N. N., Yang, C., & Cowley, A. W. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15058 · Cited by 40
Pathophysiology of diabetic kidney disease and autophagy: A review
Yu, J., Liu, Y., Li, H., & Zhang, P. (2023) · Medicine · doi:10.1097/md.0000000000033965 · Cited by 45
Improvement in Insulin Sensitivity After Human Islet Transplantation for Type 1 Diabetes
Rickels, M. R., Kong, S. M., Fuller, C., Dalton-Bakes, C., Ferguson, J. F., Reilly, M. P., Teff, K. L., & Naji, A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1764 · Cited by 34
den Hartigh, L. J., Goodspeed, L., Wang, S. A., Kenerson, H. L., Omer, M., O’Brien, K. D., Ladiges, W., Yeung, R. S. W., & Subramanian, S. (2018) · Experimental Physiology · doi:10.1113/ep087207 · Cited by 34
Rios-Fuller, T. J., Mahé, M., Walters, B., Abbadi, D., Pérez-Baos, S., Gadi, A., Andrews, J. J., Katsara, O., Vincent, C. T., & Schneider, R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155301 · Cited by 43
Small intestinal metabolism is central to whole-body insulin resistance
Angelini, G., Salinari, S., Castagneto‐Gissey, L., BERTUZZI, A., Casella-Mariolo, J. R., Ahlin, S., Boškoski, I., Gaggini, M., Raffaelli, M., Costamagna, G., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322073 · Cited by 35
Branched-Chain Amino Acids and Risk of Breast Cancer
Zeleznik, O. A., Balasubramanian, R., Ren, Y., Tobias, D. K., ROSNER, B. A., Peng, C., Bever, A. M., Frueh, L., Jeanfavre, S., Ávila-Pacheco, J., et al. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab059 · Cited by 38
Mechanistic Target of Rapamycin (mTOR) Inhibitors
Wang, D., & Eisen, H. J. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_553 · Cited by 41
Nonalcoholic fatty liver disease shows significant sex dimorphism
Chen, X., Wang, C., Huang, Y., & Zhang, L. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i5.1457 · Cited by 40
Mammalian target of rapamycin controls glucose consumption and redox balance in human Sertoli cells
Jesus, T. T., Oliveira, P. F., Silva, J., Barros, A., Ferreira, R. M., Sousa, M., Cheng, C. Y., Silva, B. M., & Alves, M. G. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.11.032 · Cited by 41
The mammalian target of rapamycin pathway and its role in molecular nutrition regulation
Lian, J., Yan, X., Peng, J., & Jiang, S. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700005 · Cited by 37
Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors
Cruzado, J. M. (2007) · Transplantation Reviews · doi:10.1016/j.trre.2007.09.003 · Cited by 36
Krakauer, T. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.08.019 · Cited by 36
Wu, L.-Y., Li, M., Qu, M., Li, X., Pi, L., Chen, Z., Zhou, S., Yi, X., Shi, X., Wu, J., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.11.025 · Cited by 33
Sajak, A. A. B., Mediani, A., Maulidiani, M., Ismail, A., & Abas, F. (2016) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-016-2352-9 · Cited by 31
Stefater, M. A., & Seeley, R. J. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104723 · Cited by 28
Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications
Yang, L., Zhang, Z., Wang, D., Jiang, Y., & Liu, Y. (2022) · Current Drug Targets · doi:10.2174/1389450123666220111115528 · Cited by 29
Comparison of rapamycin schedules in mice on high-fat diet
Leontieva, O. V., Paszkiewicz, G., & Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/15384101.2014.970491 · Cited by 27
Waise, T. M. Z., Rasti, M., Duca, F. A., Zhang, S., Bauer, P. V., Rhodes, C. J., & Lam, T. K. T. (2019) · Nature Communications · doi:10.1038/s41467-019-08582-7 · Cited by 26
Almendáriz-Palacios, C., Mousseau, D. D., Eskiw, C. H., & Gillespie, Z. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239220 · Cited by 31
mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy
Saha, S., Fang, X., Green, C. D., & Das, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015078 · Cited by 26
Geroprotector drugs and exercise: friends or foes on healthy longevity?
Elliehausen, C. J., Anderson, R. M., Diffee, G. M., Rhoads, T. W., Lamming, D. W., Hornberger, T. A., & Konopka, A. R. (2023) · BMC Biology · doi:10.1186/s12915-023-01779-9 · Cited by 27
Ananieva, E. A., Horn, C. G. V., Jones, M. R., & Hutson, S. M. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.014 · Cited by 28
Mammalian Target of Rapamycin at the Crossroad Between Alzheimer’s Disease and Diabetes
Liang, H., Nie, J., Skike, C. E. V., Valentine, J. M., & Orr, M. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_10 · Cited by 27
Ranieri, S. C., Fusco, S., & Pani, G. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00009-2 · Cited by 22
Yang, P., Zhao, Y., Zhao, L., Yuan, J., Chen, Y., Varghese, Z., Moorhead, J. F., Chen, Y., & Ruan, X. Z. (2015) · Scientific Reports · doi:10.1038/srep14959 · Cited by 21
Hunt, N. J., Wahl, D., Westwood, L. J., Lockwood, G. P., Couteur, D. G. L., & Cogger, V. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114537 · Cited by 22
Gojda, J., Rossmeislová, L., Straková, R., Tůmová, J., Elkalaf, M., Jaček, M., Tůma, P., Potočková, J., Krauzová, E., Waldauf, P., et al. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.274 · Cited by 23
Hoseini, R., Hoseini, Z., & Kamangar, A. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05836-0 · Cited by 22
Jurca, C. M., Kozma, K., Petcheși, C. D., Zaha, D. C., Magyar, I., Munteanu, M. A., Faur, L., Jurca, A. A., Bembea, D., Severin, E. M., et al. (2023) · Genes · doi:10.3390/genes14020433 · Cited by 21
Gras, F., Brunmair, B., Quarré, L., Szöcs, Z., Waldhäusl, W. K., & Fürnsinn, C. (2007) · Diabetologia · doi:10.1007/s00125-007-0836-4 · Cited by 26
Self-citationInsulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 25
Self-citationAdeva-Andany, M. M., Fernández-Fernández, C., López-Pereiro, Y., Castro-Calvo, I., & Carneiro-Freire, N. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.06.025 · Cited by 19
mTOR Signaling Pathway in Bone Diseases Associated with Hyperglycemia
Wang, S., Wang, J., Wang, S., Tao, R., Yi, J., Chen, M., & Zhao, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119198 · Cited by 22
Kahan, B. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.579898 · Cited by 19
Liao, B., & Xu, Y. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-011-1892-5 · Cited by 20
Li, X., Choi, Y. J., Yanakawa, Y., & Park, T. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.70 · Cited by 22
Bassil, M. S., Burgos, S. A., Marliss, E. B., Morais, J. A., Chevalier, S., & Gougeon, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2115-7 · Cited by 22
Szöcs, Z., Brunmair, B., Stadlbauer, K., Nowotny, P., Bauer, L., Luger, A., & Fürnsinn, C. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136465 · Cited by 21
Self-citationUntangling the genetic link between type 1 and type 2 diabetes using functional genomics
Nyaga, D. M., Vickers, M. H., Jefferies, C., Fadason, T., & O'Sullivan, J. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-93346-x · Cited by 18
Júnior, J. M. C., Rosa, M. R. R., Protzek, A. O. P., Paula, F. M. D., Ferreira, S. M., de Rezende, L. F., Vanzela, E. C., Zoppi, C. C., Silveira, L. R., Kettelhut, Í. D. C., et al. (2015) · Amino Acids · doi:10.1007/s00726-014-1903-z · Cited by 19
Cellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Tobias, D. K., Chai, B., Tamimi, R. M., Manson, J. E., Hu, F. B., Willett, W. C., & Eliassen, A. H. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab032 · Cited by 16
Soto‐Moreno, E. J., Balboula, A. Z., Spinka, C., & Rivera, R. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260123 · Cited by 17
Jamal, M., Nunes, A. C. F., Vaziri, N. D., Ramchandran, R., Bacallao, R. L., Nauli, A. M., & Nauli, S. M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114056 · Cited by 16
Randolph, A. C., Markofski, M. M., Rasmussen, B. B., & Volpi, E. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.06.017 · Cited by 17
The mystery of the ketogenic diet: benevolent pseudo-diabetes
Blagosklonny, M. V. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1644765 · Cited by 18
Ying, L., Zhang, M., Ma, X., Si, Y., Li, X., Su, J., Yin, J., & Bao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.672032 · Cited by 14
Thompson, N. M., Huber, K., Bedürftig, M., Hansen, K., Miles-Chan, J. L., & Breier, B. H. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-50 · Cited by 19
Rigamonti, A. E., Frigerio, G., Caroli, D., Col, A. D., Cella, S. G., Sartório, A., & Fustinoni, S. (2023) · Nutrients · doi:10.3390/nu15030529 · Cited by 15
Li, C., Yang, Q., & Zhang, L. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2290458 · Cited by 14
Benedini, S., Ermetici, F., Briganti, S., Codella, R., Terruzzi, I., Maffi, P., Caldara, R., Secchi, A., Nano, R., Piemonti, L., et al. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1141-z · Cited by 13
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch17 · Cited by 22
Self-citationSchwanstecher, C., & Schwanstecher, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_1 · Cited by 13
Tomato Powder Modulates NF-κB, mTOR, and Nrf2 Pathways during Aging in Healthy Rats
Şahin, K., Orhan, C., Tuzcu, M., Taştan, H., Bilir, B., Şahin, N., Öner, D. A., & Küçük, Ö. (2019) · Journal of Aging Research · doi:10.1155/2019/1643243 · Cited by 10
Tuberous Sclerosis Complex: New Insights into Pathogenesis and Therapeutic Breakthroughs
Jurca, A. A., Jurcă, A. D., Petcheși, C. D., Bembea, D., Jurca, C. M., Severin, E. M., Jurca, S., & Vesa, C. M. (2025) · Life · doi:10.3390/life15030368 · Cited by 14
Molecular Basis of Insulin Resistance and Its Relation to Metabolic Syndrome
Arora, S. (2012) · InTech eBooks · doi:10.5772/50337 · Cited by 12
Molekulare Mechanismen der Anpassungsfähigkeit der Skelettmuskulatur
Hoppeler, H. H., Baum, O., Müller, M., & Lurman, G. J. (2011) · Bern Open Repository and Information System (University of Bern) · doi:10.7892/boris.6353 · Cited by 22
Brewer, P. D., Romenskaia, I., & Mastick, C. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006986 · Cited by 9
Peripheral tissular analysis of rapamycin’s effect as a neuroprotective agent in vivo
González-Alcocer, A., Gopar‐Cuevas, Y., Soto‐Domínguez, A., Loera‐Arias, M. D. J., Cárdenas, O. S., Montes‐de‐Oca‐Luna, R., Rodríguez‐Rocha, H., & García‐García, A. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02276-6 · Cited by 8
Novel Aspects on Insulin Resistance: A Quick Overview
Anderwald, C. H. (2009) · The Endocrinologist · doi:10.1097/ten.0b013e3181c0479d · Cited by 9
Self-citationBranched chain amino acids and risk of breast cancerPreprint
Zeleznik, O. A., Balasubramanian, R., Ren, Y., Tobias, D. K., ROSNER, B. A., Peng, C., Bever, A. M., Frueh, L., Clish, C. B., Mora, S., et al. (2020) · medRxiv · doi:10.1101/2020.08.31.20185470 · Cited by 8
Stanfield, B., Kaeberlein, M. R., Leroux, B. G., Jones, J. P., Lucas, R., & Arroll, B. (2024) · Trials · doi:10.1186/s13063-024-08490-2 · Cited by 7
Sun, R., Zhang, Y., Ma, S., Qi, H.-T., Wang, M., Duan, J.-H., Ma, S., Zhu, X., Li, G., & Wang, H. (2015) · Microbiology and Immunology · doi:10.1111/1348-0421.12321 · Cited by 7
Younis, H. S., Hirakawa, B. P., Scott, W., TRAN, P. H., Bhat, G. J., Affolter, T., Chapman, J., Heyen, J., Chakravarty, K., & Alton, G. (2010) · Pharmacology · doi:10.1159/000322526 · Cited by 8
LPS-induced biomarkers in mice: A potential model for identifying insulin sensitizers
Briscoe, C. P., Looper, D., Tran, P. H., Herrera, J., McDonnell, S. R. P., & Bhat, B. G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.164 · Cited by 6
Westfall, S., & Lomis, N. (2016) · Journal of Microbial & Biochemical Technology · doi:10.4172/1948-5948.1000297 · Cited by 8
Abolbaghaei, A., Oomah, B. D., Tavakoli, H., & Hosseinian, F. S. (2018) · Journal of Food Bioactives · doi:10.31665/jfb.2018.2136 · Cited by 7
Stanfield, B., Leroux, B., Kaeberlein, M. R., Jones, J., & Lucas, R. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70274 · Cited by 11
Melnik, B. C., Weiskirchen, R., John, S. M., Stremmel, W., Leitzmann, C., Weiskirchen, S., & Schmitz, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104493 · Cited by 6
Insulin Resistance, Secretion and Clearance –Taming the Three Effector Encounter of Type 2 Diabetes
Bar‐Tana, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.741114 · Cited by 5
Stadlbauer, K., Brunmair, B., Szöcs, Z., Krebs, M., Luger, A., & Fürnsinn, C. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00061.2009 · Cited by 5
Self-citationSoliman, G. A., & Schooling, C. M. (2022) · Current Developments in Nutrition · doi:10.1093/cdn/nzac044 · Cited by 6
Impact of Dietary Proteins on Energy Balance, Insulin Sensitivity and Glucose Homeostasis
Chevrier, G., Mitchell, P. L., Beaudoin, M., & Marette, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802167-5.00018-9 · Cited by 6
Macías-Acosta, M. P., Valerdi-Contreras, L., Bustos-Angel, E. D., García-Reyes, R. A., Álvarez-Zavala, M., & González‐Ávila, M. (2021) · Amino Acids · doi:10.1007/s00726-021-03107-3 · Cited by 4
The Metabolic Syndrome in Hispanics – The Role of Insulin Resistance and Inflammation
Pablo, I., Jose, M., Escobales, N., Crespo, M., & Hector, L. (2012) · InTech eBooks · doi:10.5772/54620 · Cited by 4
Wang, J., Liu, L., Liu, H., Qian, Y., Zhang, S., Zheng, S., Jiang, H., Zhou, Y., Cheng, X., Fu, Q., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102327 · Cited by 5
Remote ischemic conditioning: A potential therapeutic strategy of type 2 diabetes
Liu, J., Sun, X., Jin, H., Yan, X., Huang, S., Guo, Z., & Yang, Y. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110409 · Cited by 4
Lees, M. J., Hodson, N. W., Tinline‐Goodfellow, C. T., Fung, H. J. W., Elia, A., & Moore, D. R. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2022 · Cited by 3
Factors Associated With Insulin Resistance After Long-Term Renal Transplantation
Şaşak, G., Sezer, S., Çolak, T., Acar, F. N. Ö., & Haberal, M. A. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.01.047 · Cited by 3
Protein metabolism in health and diabetes
Volpi, E., & Dickinson, J. M. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch16 · Cited by 3
Wu, X., & Garvey, W. T. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch7 · Cited by 6
Role of branched chain amino acid metabolism on aging
Wang, Z., Yu, S., Du, X., Yan, X., & Xin, Y. (2025) · Biogerontology · doi:10.1007/s10522-025-10309-9 · Cited by 2
Prevention of Obesity, Diabetes, and Cancer with Lifestyle Intervention Strategies
Junco, J. J., & Slaga, T. J. (2012) · CRC Press eBooks · doi:10.1201/b12893-8 · Cited by 2
Weight Loss and Branched Chain Amino Acids and Their Metabolites
Laferrère, B., Pietiläinen, K. H., & Boirie, Y. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1914-7_20 · Cited by 2
Hepatic Carbohydrate Metabolism
Raddatz, D., & Ramadori, G. P. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_8 · Cited by 5
Binkhathlan, Z., Alshememry, A. K., Balkhair, A. M., Ali, R., Alhudaithi, S. S., Alobid, S. E., Qamar, W., Aodah, A. H., Vakili, M. R., & Lavasanifar, A. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100341 · Cited by 1
Metadata
- Authors
- Krebs, M., Brunmair, B., Brehm, A., Artwohl, M., Szendroedi, J., Nowotny, P., Roth, E., Fürnsinn, C., Promintzer, M., Anderwald, C., Bischof, M., & Roden, M.
- Affiliations
- Medical University of Vienna (AT)
- Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
- Hanusch Hospital (AT)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-06-01
- Volume
- 56
- Issue
- 6
- Pages
- 1600-1607
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2156080804
- Cited by
- 230
- References
- 50
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 5 · 2023: 12 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 10 · 2018: 9 · 2017: 7 · 2016: 12 · 2015: 12 · 2014: 16 · 2013: 11 · 2012: 15
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk
- Österreichische Diabetes Gesellschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- mTOR, S6 kinase, rapamycin, glucose uptake, insulin sensitivity, hyperinsulinemia, hyperaminoacidemia, skeletal muscle, IRS-1 phosphorylation, endogenous glucose production, glucose turnover, insulin resistance
- MeSH terms
- Adult, Amino Acids, Biological Transport, Blood Glucose, C-Peptide, Fatty Acids, Nonesterified, Glucagon, Glucose, Humans, Insulin, Male, Protein Kinases, Reference Values, Human Growth Hormone, Sirolimus, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.